Cargando…

Viral Load, Integration and Methylation of E2BS3 and 4 in Human Papilloma Virus (HPV) 16-Positive Vaginal and Vulvar Carcinomas

OBJECTIVE: To investigate if viral load, integration and methylation of E2BS3 and 4 represent different ways of tumor transformation in vaginal and vulvar carcinoma and to elucidate its clinical impact. METHODS: Fifty-seven samples, positive for HPV16, were selected for the study. Detection of viral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lillsunde Larsson, Gabriella, Helenius, Gisela, Sorbe, Bengt, Karlsson, Mats G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231157/ https://www.ncbi.nlm.nih.gov/pubmed/25393237 http://dx.doi.org/10.1371/journal.pone.0112839

Ejemplares similares

HPV16 viral characteristics in primary, recurrent and metastatic vulvar carcinoma
por: Lillsunde Larsson, Gabriella, et al.
Publicado: (2018)

HPV-negative Tumors in a Swedish Cohort of Cervical Cancer
por: Kaliff, Malin, et al.
Publicado: (2020)

Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy
por: Kaliff, Malin, et al.
Publicado: (2018)

Does p53 codon 72 polymorphism have a prognostic value in carcinoma of the vulva and vagina?
por: Qvick, Alvida, et al.
Publicado: (2017)

Digital droplet PCR (ddPCR) for the detection and quantification of HPV 16, 18, 33 and 45 - a short report
por: Lillsunde Larsson, Gabriella, et al.
Publicado: (2017)

HPV-based screening for cervical cancer among women 55-59 years of age
por: Bergengren, Lovisa, et al.
Publicado: (2019)

Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda
por: Kumakech, Edward, et al.
Publicado: (2016)

Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma
por: Ranhem, Cecilia, et al.
Publicado: (2017)

Evaluation of dyskerin expression and the Cajal body protein WRAP53β as potential prognostic markers for patients with primary vaginal carcinoma
por: Ranhem, Cecilia, et al.
Publicado: (2022)

Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk human papillomavirus–positive samples from women over 30 years participating in cervical cancer screening in Örebro, Sweden
por: Kaliff, Malin, et al.
Publicado: (2022)

Molecular triage of cervical screening samples in women 55–59 years of age: a pilot study
por: Helenius, Gisela, et al.
Publicado: (2023)

Detection of High- and Low-Risk HPV DNA in Archived Breast Carcinoma Tissues from Ethiopian Women
por: Gebregzabher, Endale, et al.
Publicado: (2021)

Age-Stratified Analysis of Vaginal Microbiota Dysbiosis and the Relationship with HPV Viral Load in HPV-Positive Women
por: Li, Mingzhu, et al.
Publicado: (2022)

Significance of HPV16 Viral Load Testing in Anal Cancer
por: Małusecka, Ewa, et al.
Publicado: (2020)

Evaluation of Human Papilloma Virus (HPV) Genotyping and Viral Load Determination as Diagnostic Biomarkers of Cervical Cancer Risk
por: Martinelli, Marianna, et al.
Publicado: (2023)

Effectiveness and costs of an implemented primary HPV cervical screening programme in Sweden – A population based cohort study
por: Bergengren, Lovisa, et al.
Publicado: (2021)

HPV status and HPV16 viral load in anal cancer and its association with clinical outcome
por: Guerendiain, Daniel, et al.
Publicado: (2022)

Incidence of oncogenic HPV and HPV-related dysplasia five years after a negative HPV test by self-sampling in elderly women
por: Hermansson, Ruth S., et al.
Publicado: (2022)

Efficacy of HPV Vaccination Regarding Vulvar and Vaginal Recurrences in Previously Treated Women: The Need for Further Evidence
por: Bechini, Angela, et al.
Publicado: (2023)

Ospemifene for vulvar and vaginal atrophy: an overview
por: Palacios, Santiago
Publicado: (2020)

Global availability of data on HPV genotype-distribution in cervical, vulvar and vaginal disease and genotype-specific prevalence and incidence of HPV infection in females
por: Wagner, Monika, et al.
Publicado: (2015)

Vulvar Buschke-Löwenstein tumor in a HPV 16 infected woman: case report
por: Ernez, Safia, et al.
Publicado: (2022)

HPV prevalence in vulvar cancer in Austria
por: Pils, Sophie, et al.
Publicado: (2017)

Anti-HPV16 E2 Protein T-Cell Responses and Viral Control in Women with Usual Vulvar Intraepithelial Neoplasia and Their Healthy Partners
por: Jacobelli, Simon, et al.
Publicado: (2012)

No association between HPV positive breast cancer and expression of human papilloma viral transcripts
por: Gannon, Orla M., et al.
Publicado: (2015)

Microbiota and HPV: The role of viral infection on vaginal microbiota
por: Santella, Biagio, et al.
Publicado: (2022)

HPV viral load in self-collected vaginal fluid samples as predictor for presence of cervical intraepithelial neoplasia
por: Berggrund, Malin, et al.
Publicado: (2019)

HPV-associated vulvar carcinoma with sebaceous differentiation
por: Kuan, Irena, et al.
Publicado: (2023)

HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix
por: Long, Wenbo, et al.
Publicado: (2018)

The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer
por: Sznurkowski, Jacek J., et al.
Publicado: (2016)

Clinicopathological Implications of Human Papilloma Virus (HPV) L1 Capsid Protein Immunoreactivity in HPV16-Positive Cervical Cytology
por: Lee, Sung-Jong, et al.
Publicado: (2013)

STAT1 expression and HPV16 viral load predict cervical lesion progression
por: Wu, Si, et al.
Publicado: (2020)

Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16
por: Hong, Die, et al.
Publicado: (2017)

Human papillomavirus in vulvar and vaginal carcinoma cell lines
Publicado: (1995)

Human papillomavirus in vulvar and vaginal carcinoma cell lines.
por: Hietanen, S., et al.
Publicado: (1995)

Vulvar and Vaginal Melanomas—The Darker Shades of Gynecological Cancers
por: Dobrică, Elena-Codruța, et al.
Publicado: (2021)

Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices
por: Goldstein, Irwin, et al.
Publicado: (2019)

Evaluation of alternately combining HPV viral load and 16/18 genotyping in secondary screening algorithms
por: Luo, Hongxue, et al.
Publicado: (2019)

Association of viral load and physical status of HPV-16 with survival of patients with head and neck cancer
por: Veitía, Dayahindara, et al.
Publicado: (2020)

Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause
por: Pięta, Wojciech, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1hmm9kgk609go813v6tjon8odk